Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mometasone nasal spray versus montelukast plus mometasone for severe adenoid hypertrophy in children
IRCT20260626069952N1Phase 3Recruiting
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Oct 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in adenoidal hypertrophy comparing Mometasone + placebo with Montelukast + mometasone (2 arms). Primary endpoint: Reduction in adenoid size. Started Oct 2026; status: recruiting.
02
Drugs
mometasonemontelukast
03
Conditions
adenoidal hypertrophy
Beyond the preview
Go deeper on IRCT20260626069952N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260626069952N1.